 Artist: Deepchord: mp3 download Genre(s): Other Electronic Discography:  Vantage Isle Vinyl Year: 2007 Tracks: 10  The Coldest Season Part 2 Year: 2007 Tracks: 2  The Coldest Season Part 1 Year: 2007 Tracks: 2 If imitation is the sincerest sort of flattery, the fellows in Berlin's Rhythm & Sound camp testament take no trouble endorsing Detroit-based Deepchord as their dub-techno successor apparent. Already an established ambient producer, Rod Modell partnered with Mike Schommer, quietly releasing their first 12" together in the late '90s. Like Rhythm & Sound, Deepchord based their compositions around minimal arrangements: repetitious rhythms divine by dub, dim traces of theodore Harold White noise, and quick synth stabs. The group maintained a patriotic cult undermentioned, psychotherapeutic several more singles in the early 2000s as well as a limited-run CD reading of their first six releases (in the beginning pressed up in highly limited quantities). The duo's production went from fertile to a screech staunch more or less 2002, qualification a remarkable and rare unrecorded performance at the Detroit Electronic Music Festival and cathartic singles in a scarce fashion (the group's 2006 single was just when pressed to 100 copies). A retrospective of the group's work, Vibrasound: 1999-2004, was issued under Modell's name and released on the Silentes tag in 2005. Later that year, Modell teamed with Kevin Hanton to release Illuminati Audio Science and used a generous share of the group's output signal, looped and chopped into little segments (a great deal like Richie Hawtin's DE9 experiments), for a continuous 70-minute mix in CD. |
Saturday, 30 August 2008
Download Deepchord mp3
Wednesday, 20 August 2008
Comparing Intermittent To Continuous Androgen Deprivation For Advanced Prostate Cancer
�UroToday.com - Dr. Arto Salonen and Finnish colleagues compared intermittent androgen deprivation (IAD) to continuous androgen deprivation (CAD) in 856 patients with locally advanced or metastatic prostate crab (CaP) treated at 27 clinics in Finland. This report represents an meantime analysis of their information.
The patients were accrued between 1997 and 2003 and had a life expectancy of at least 12 months. A 24 week run in of continuous LHRH agonist therapy preceded randomization for those who had a PSA decrease to
Mean patient age was 72 age and mean PSA at entry was 383ng/ml. Patients had phase T3 tumors (61%) and stage T4 tumors (29%). A total of 564 men completed the row period and 279 were randomized to IAD and 285 to CAD. PSA, alkaline phosphatase, proportion of T4 tumors, poorly differentiated tumors, metastatic disease, and skeletal hot spots among patients with M1 disease were significantly higher in the IAD group. Baseline testosterone was not significant in the analysis.
A significant proportion of patients with the most aggressive and advanced CaP did not respond to androgen deprivation therapy. The investigators concluded that IAD appears feasible for patients with locally advanced, hormone sensitive CaP. A low terminus ad quem of testosterone at baseline did not select for IAD or CAD. Patients with advanced CaP, with a high PSA, alkalic phosphatase and metastatic disease, with more than 5 skeletal hot spots, did not show adequate biochemical response to ADT. Thus, they ar not good candidates for IAD and other modalities should be considered.
Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K, Tammela TL
J Urol. 2008 Jul 15. Epub ahead of print.
doi:10.1016/j.juro.2008.05.009
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by planetary urology key opinion leaders actively engaged in clinical practice.
To access the modish urology news releases from UroToday, go to:
www.urotoday.com
Copyright � 2008 - UroToday
More info
The patients were accrued between 1997 and 2003 and had a life expectancy of at least 12 months. A 24 week run in of continuous LHRH agonist therapy preceded randomization for those who had a PSA decrease to
Mean patient age was 72 age and mean PSA at entry was 383ng/ml. Patients had phase T3 tumors (61%) and stage T4 tumors (29%). A total of 564 men completed the row period and 279 were randomized to IAD and 285 to CAD. PSA, alkaline phosphatase, proportion of T4 tumors, poorly differentiated tumors, metastatic disease, and skeletal hot spots among patients with M1 disease were significantly higher in the IAD group. Baseline testosterone was not significant in the analysis.
A significant proportion of patients with the most aggressive and advanced CaP did not respond to androgen deprivation therapy. The investigators concluded that IAD appears feasible for patients with locally advanced, hormone sensitive CaP. A low terminus ad quem of testosterone at baseline did not select for IAD or CAD. Patients with advanced CaP, with a high PSA, alkalic phosphatase and metastatic disease, with more than 5 skeletal hot spots, did not show adequate biochemical response to ADT. Thus, they ar not good candidates for IAD and other modalities should be considered.
Salonen AJ, Viitanen J, Lundstedt S, Ala-Opas M, Taari K, Tammela TL
J Urol. 2008 Jul 15. Epub ahead of print.
doi:10.1016/j.juro.2008.05.009
Reported by UroToday.com Contributing Editor Christopher P. Evans, MD, FACS
UroToday - the only urology website with original content written by planetary urology key opinion leaders actively engaged in clinical practice.
To access the modish urology news releases from UroToday, go to:
www.urotoday.com
Copyright � 2008 - UroToday
More info
Sunday, 10 August 2008
Folk review: Joan Baez, Day After Tomorrow
Grasslands, twist in your hair, long, dusty roadstead travelled - it's all evoked in Joan's fine 24th studio album, and her voice, high and flowing, low and gravelly, flows timelessly through it like a mountain current. Guided by the heavy, gentle hands of producer Steve Earle, she sings songs by her favourite writers (just no Dylan here), including T-Bone Burnett, Elvis Costello, and Tom Waits (the title track). Classy, magic, and 67, she ponders her loss, but strives on: 'Every day on Earth's another chance to get it right...'
More info
Subscribe to:
Posts (Atom)